ECM
CGON icon

ExodusPoint Capital Management’s CG Oncology CGON Stock Holding History

ExodusPoint Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,850
Closed -$840K – 1597
2025
Q3 		$840K Buy
+20,850
New +$606K 0.01% 1022

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ExodusPoint Capital Management's CGON Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 20,850 shares — an estimated $840K sold.

ExodusPoint Capital Management first reported a position in CGON in Q3 2025 and held it in 1 quarter. The position peaked at $840K in Q3 2025. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 20,850 CG Oncology shares in Q4 2025, an estimated $840K.
  • ExodusPoint Capital Management first reported a position in CG Oncology in Q3 2025 and held it in 1 quarter.
  • ExodusPoint Capital Management's CG Oncology position peaked at $840K in Q3 2025.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.